4168.TWO · GLYCONEX INC.
Taiwan · RS rating 37 · As of 2026-10-08
| Price | 22.80 TWD |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 65 / 30 / 38 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 28 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +26.9% |
| Sales growth Q/Q | -84.2% |
| Distance from 52-week high | +22.4% |
| Market cap (USD) | $78.9M |